← Open Payments lookup

MICHAEL JOHNSON: Open Payments

NPI 1033223995 · FOXWORTH, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$481 in 26 payments from 10 companies in 2025. Trend: 2023 $252 · 2024 $336 · 2025 $481

Food & beverage: $481
CompanyPaymentsAmount
PFIZER INC.11$211
Novo Nordisk Inc4$67
AstraZeneca Pharmaceuticals LP3$56
Lilly USA, LLC2$34
Takeda Pharmaceuticals U.S.A., Inc.1$25
Bayer Healthcare Pharmaceuticals Inc.1$25
Salix Pharmaceuticals, a division of Bausch Health US, LLC1$23
ABBVIE INC.1$19
Boehringer Ingelheim Pharmaceuticals, Inc.1$16
Phathom Pharmaceuticals, Inc.1$6

Products named: NURTEC ODT, Ozempic, ELIQUIS, BREZTRI, MOUNJARO, TRINTELLIX, Kerendia, XIFAXAN.

Industry payments across MS — which companies pay providers there.